Company news
Hikma Pharmaceuticals Plc (LSE:HIK) news
Hikma Pharmaceuticals Plc news releases on 6ix. Latest, Apr 12, 2023: Directorate Change
Press releases — page 2
Directorate Change
April 12, 2023
Additional Listing
January 10, 2023
Hikma launches sodium oxybate in the US
January 3, 2023
Hikma Injectables Portugal site visit
November 30, 2022
Director changes and update on AGM 2022 resolution
September 30, 2022
Change of Hikma interim dividend payment date
September 14, 2022
Hikma launches RYALTRIS
August 30, 2022
Siggi Olafsson to step down as Chief Executive
May 24, 2022
Results of EGM
May 20, 2022
Share Buyback Programme
May 11, 2022
Hikma updates Generics guidance for 2022
May 5, 2022
Correction statement re Opiant
April 29, 2022
Notice of GM
April 25, 2022
Acquisition
April 21, 2022
FTC preliminary approval for Custopharm
April 20, 2022
Annual Financial Report
March 17, 2022
Hikma Share Buyback Programme
February 25, 2022
Hikma completes acquisition of Teligent
February 3, 2022
Hikma Launches 503B Sterile Compounding Business
January 10, 2022
Richter and Hikma sign agreement for denosumab
December 9, 2021
Hikma acquires Custopharm
September 27, 2021
Bio-Thera and Hikma announce exclusive agreement
August 27, 2021
Hikma announces US FDA approval of KLOXXADO
April 30, 2021
Hikma resumes launch of generic Advair Diskus®
April 21, 2021
Hikma and GSK agree to cease potential acquisition
March 11, 2021
Potential Acquisition
January 26, 2021
Hikma provides update on generic Advair Diskus®
January 15, 2021
Hikma launches generic Advair Diskus®
December 17, 2020
Hikma launches Icosapent Ethyl Capsules
November 5, 2020
Notice to Bondholders
October 22, 2020
Blocklisting Application
October 8, 2020
Hikma updates on ANDA for generic Advair Diskus®
September 22, 2020
Hikma receives favourable court ruling
September 3, 2020
Hikma receives FDA approval for generic Vascepa®
May 22, 2020
AGM Update
April 2, 2020
Hikma's favourable ruling in generic Vascepa®
March 31, 2020
Board Committee Changes
February 27, 2020
Hikma enters agreement to commercialise RyaltrisT
February 27, 2020
Hikma announces agreement with Chiesi Group
January 13, 2020
Hikma announces agreement with Arecor
January 9, 2020
Civica Rx and Hikma announce shipment of medicines
December 10, 2019
Hikma completes FDA response for generic Advair®
November 27, 2019
Block Listing Application
November 8, 2019
Hikma launches prefilled syringes in the US
September 17, 2019
Notice of Accession of Guarantor
September 10, 2019
Hikma expands nasal spray capabilities
August 9, 2019
Hikma and Richter sign agreement for cariprazine
July 25, 2019
Hikma and Civica Rx sign long-term agreement
July 23, 2019
Hikma launches 100th injectable medicine in US
May 1, 2019
Hikma establishes partnership with Melinta in MENA
February 28, 2019